Consistently, the AF‐dependent upregulation of different antioxidant proteins (Nrf2, HO‐1, and NQO‐1) was suppressed by BSO (Figure 6J, p < .001 compared to the SCI + AF treatment group). The gene discussed is HMOX1; the disease is atrial fibrillation.